Author pages are created from data sourced from our academic publisher partnerships and public sources.
Share This Author
A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease.
- M. Lordkipanidzé, C. Pharand, E. Schampaert, J. Turgeon, D. Palisaitis, J. Diodati
- Medicine, BiologyEuropean heart journal
- 1 July 2007
Six major platelet function tests are not equally effective in measuring aspirin's antiplatelet effect and correlate poorly amongst themselves, and the clinical usefulness of the different assays to classify correctly patients as aspirin resistant remains undetermined.
Comparison of four tests to assess inhibition of platelet function by clopidogrel in stable coronary artery disease patients.
- M. Lordkipanidzé, C. Pharand, Thuy Anh Nguyen, E. Schampaert, D. Palisaitis, J. Diodati
- Biology, MedicineEuropean heart journal
- 1 December 2008
The assessment of platelet function inhibition by clopidogrel is highly test-specific, thus highlighting the need for unambiguous guidelines with respect to assay selection, as Platelet function assays are not interchangeable.
Sirolimus-eluting stents at two years: a pooled analysis of SIRIUS, E-SIRIUS, and C-SIRIUS with emphasis on late revascularizations and stent thromboses.
Aspirin resistance: truth or dare.
Genetic determinants of response to aspirin: appraisal of 4 candidate genes.
Insights into the interpretation of light transmission aggregometry for evaluation of platelet aggregation inhibition by clopidogrel.
The Vancouver 3M (Multidisciplinary, Multimodality, But Minimalist) Clinical Pathway Facilitates Safe Next-Day Discharge Home at Low-, Medium-, and High-Volume Transfemoral Transcatheter Aortic Valve…
Platelet count, not oxidative stress, may contribute to inadequate platelet inhibition by aspirin.
Heterogeneity in platelet cyclooxygenase inhibition by aspirin in coronary artery disease.